Breast-Feeding While on Seizure Meds Doesn't H... ( Study finds no negative impact on chi...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Breast-Feeding While on Seizure Meds Doesn't Harm Babies

Date:4/17/2008

Study finds no negative impact on children's cognitive development

THURSDAY, April 17 (HealthDay News) -- Mothers who breast-feed while on certain seizure medications do not appear to harm their children's cognitive development, a new study finds.

"Our early findings show breast-feeding during anti-epilepsy drug treatment doesn't appear to have a negative impact on a child's cognitive abilities," study author Kimford Meador, of the University of Florida at Gainesville, said in a prepared statement. "However, more research is needed to confirm our findings, and women should use caution due to the limitations of our study."

The study was expected to be presented Thursday at the American Academy of Neurology annual meeting, in Chicago.

The cognitive development of 187 2-year-old children whose mothers were taking the epilepsy drugs lamotrigine, carbamazepine, phenytoin or valproate were tested in the study. Of these children, 41 percent were breast-fed.

The children of mothers who breast-fed while on the epilepsy medications actually scored consistently higher on IQ tests than those children in the study who were not breast-fed. However, the results were not significantly different after adjusting for the mother's intelligence as the children who were breast-fed also had higher IQs.

While animal studies have shown that some anti-epilepsy drugs can cause cells death in immature brains, Meador said beta estradiol, which is the mother's sex hormone, is thought to prevent that from occurring.

The study will continue and, ultimately, examine the effects of in utero anti-epilepsy drug exposure on children at 6 years old.

More information

The Epilepsy Foundation has more about epilepsy.

-- Kevin McKeever

'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Breast-Feeding Doesnt Contribute to Cavities
2. Successful Breast-Feeding
3. Breast-Feeding Confers Long-Term Heart Benefits
4. Breast-Feeding Cuts Food Allergy Risk
5. Breast-Feeding Seems to Protect Against Some Allergies
6. Breast-Feeding Protected Mice From Asthma
7. Drug Helps Prevent Breast-Feeding Moms From Passing on HIV
8. Another Reason Not to Smoke While Pregnant: Birth Defects
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
11. Mecklenburg EMS Agency Launches Innovative Program to Pay Future EMTs While They Train

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Soy Beneficial for Breast Cancer Survivors: Study 2 Health News:Soy Beneficial for Breast Cancer Survivors: Study 3 Health News:Researchers Use New Techniques to Assess PTSD 2 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21 Health News:Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know 2 Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2 Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3 Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4 Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5 Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6

[0] Soy Beneficial for Breast Cancer Survivors: Study [1] Researchers Use New Techniques to Assess PTSD [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[1] Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know [1] Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

Other Medicine News:Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2 Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3 Health News:Stigma Keeps Teens From Depression Treatment 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 3 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 4 Health News:Gyminee Raises 525K and Relaunches as DailyBurn 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 3 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 4 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 5 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3

Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex Stigma Keeps Teens From Depression Treatment The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite Gyminee Raises 525K and Relaunches as DailyBurn Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making

Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2 10 students receive scholarships for outstanding work in public health systems research 50092 1

[0] Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities [0] Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 [0] Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective

Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Medicine Products:

STA STACHROM PROTEIN C ASSERACHROM PROTEIN C STA ROTACHROM HEPARIN 4 STA DEFICIENT X